Sanofi US Services at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Sanofi US Services at ASHG 2026 in Montréal: 1 presentation (1 poster).

Organization	ASHG 2026 Attendance
Sanofi US Services Cambridge, Massachusetts	1 Principal Scientist
sanofi.com Subsidiary~13,000 people Sanofi develops medicines and vaccines for patients worldwide across specialty care and general medicines. Won EU approval to give its meningitis vaccine MenQuadfi to infants as young as six weeks, widening its pediatric vaccine market. › Won EU approval to give its meningitis vaccine MenQuadfi to infants as young as six weeks, widening its pediatric vaccine market. 2026-08 · source Restructured its executive committee into a more focused leadership team across its business and scientific functions. 2026-07 · source Won US approval for a subcutaneous, on-body-injector version of its myeloma drug Sarclisa, offering patients a faster at-home option. 2026-07 · source Source: company newsroom Q2 2026 sales €11.6B, up 16% reported › 2026 guidance calls for about 10% sales growth at constant exchange rates. · 2026-07-30 “Net sales \| €11,597m \| +16.0% \| +17.8%; In 2026, sales are now expected to grow by around 10% at CER.” Source: results release Currently hiring: 250 open roles › Source: careers page	Poster Thu Oct 22 4:15 pm Part of Statistical Genetics and Genetic Epidemiology Poster Thursday Session Multi-omics evidence for type 2 diabetes in vascular dementia risk: implications for GLP-1 receptor agonists in neuroprotection Exhibit & Poster Hall · Board 8430T Alzheimer’s diseaseBrain/nervous systemMetabolic disorderMulti-omics

Organization

ASHG 2026 Attendance

Sanofi US Services

Cambridge, Massachusetts

1 Principal Scientist

sanofi.com

Subsidiary~13,000 people

Sanofi develops medicines and vaccines for patients worldwide across specialty care and general medicines.

Won EU approval to give its meningitis vaccine MenQuadfi to infants as young as six weeks, widening its pediatric vaccine market.

›

Won EU approval to give its meningitis vaccine MenQuadfi to infants as young as six weeks, widening its pediatric vaccine market.

2026-08 · source

Restructured its executive committee into a more focused leadership team across its business and scientific functions.

2026-07 · source

Won US approval for a subcutaneous, on-body-injector version of its myeloma drug Sarclisa, offering patients a faster at-home option.

2026-07 · source

Source: company newsroom

Q2 2026 sales €11.6B, up 16% reported

›

2026 guidance calls for about 10% sales growth at constant exchange rates. · 2026-07-30

“Net sales | €11,597m | +16.0% | +17.8%; In 2026, sales are now expected to grow by around 10% at CER.”

Source: results release

Currently hiring: 250 open roles

›

Source: careers page

Poster

Thu Oct 22
4:15 pm

Part of Statistical Genetics and Genetic Epidemiology Poster Thursday Session

Multi-omics evidence for type 2 diabetes in vascular dementia risk: implications for GLP-1 receptor agonists in neuroprotection

Exhibit & Poster Hall · Board 8430T

Alzheimer’s diseaseBrain/nervous systemMetabolic disorderMulti-omics

Instantly find 20 buyers from Sanofi US Services

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction